Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-010453 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
2,000
Total Value
$131,629.52
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 2, 2026 | Sale | 792 | $65.21 | $51,646.32 | 184,579 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 2, 2026 | Sale | 1,108 | $66.15 | $73,294.20 | 183,471 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 2, 2026 | Sale | 100 | $66.89 | $6,689.00 | 183,371 | Direct | โ | View Details |